Novonesis (Novozymes) A/S (NSIS-B)
Copenhagen Exchange · Denmark · prices in DKK · close of 22 Oct 2026
Key indicators
| Last close | DKK 479.00 |
|---|---|
| 52-week range | 336.80 – 479.00 |
| Return, 1 month / 3 months | +8.6% / +13.4% |
| Return, 1 year / 3 years | +19.3% / +76.8% |
| Trend | Uptrend |
| RSI (14) | 75 |
| Volatility (1 year) | 27.0% |
| Worst drawdown (1 year) | -19.6% |
| Average daily value traded | 265.64M DKK |
| Dividend yield | 1.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Novonesis, formerly Novozymes, is a Danish industrial biotechnology company based near Copenhagen. It makes enzymes and microorganisms that customers use in food and beverages, household care products such as detergents, animal feed and agriculture, and industrial processes including biofuels. Its products include enzymes for baking, brewing and textile treatment, along with microbial cultures and probiotics for dairy and health applications. Customers are manufacturers and processors across these industries who use the ingredients to improve their own production.
Novonesis (Novozymes) A/S trades under the code NSIS-B on the Copenhagen Exchange in Denmark, with its price quoted in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Novonesis (Novozymes) A/S (NSIS-B) trades on the Copenhagen Exchange in Denmark. It last closed at DKK 479.00 on 22 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 12 of 164 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.3% and over the last three months it rose 13.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Copenhagen Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.5% | ||
| From 52-week high | 0.0% | ||
| Momentum | 77 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 13.4% | ||
| 6-month return | 25.6% | ||
| 12-month return, skipping the last month | 9.8% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.6% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 265.64M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.4% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.6% |
|---|---|
| 1 month | +8.6% |
| 3 months | +13.4% |
| 6 months | +25.6% |
| 1 year | +19.3% |
| 3 years | +76.8% |
| 5 years | +15.3% |
Signals
| 50-day / 200-day average | 438.49 / 400.71 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.99 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Aug 2026 | DKK 2.3500 |
| 24 Mar 2026 | DKK 4.2500 |
| 21 Aug 2025 | DKK 2.2500 |
| 4 Apr 2025 | DKK 4.2000 |
| 29 Aug 2024 | DKK 2.0000 |
| 1 May 2024 | DKK 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Copenhagen Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.